Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection

Induction of an Antiviral State and Attenuated Coxsackievirus Replication in Type III Interferon-Treated Primary Human Pancreatic Islets

(2013) K. Lind et al.   JOURNAL OF VIROLOGY

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

(2013) Ludmila Prokunina-Olsson et al.   NATURE GENETICS

Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor

(2013) Jung-Yen Liu et al.   Pathogens and Disease

HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III Interferons

(2012) Emmanuel Thomas et al.   GASTROENTEROLOGY

IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

(2012) Heiyoung Park et al.   HEPATOLOGY

Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent

(2012) Philippa Hillyer et al.   IMMUNOLOGY AND CELL BIOLOGY

The interferons and their receptors-distribution and regulation

(2012) Nicole A de Weerd et al.   IMMUNOLOGY AND CELL BIOLOGY

Interferon-lambda (IFN- ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes

(2012) H. Dickensheets et al.   JOURNAL OF LEUKOCYTE BIOLOGY

IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication

(2012) H. Shindo et al.   JOURNAL OF VIRAL HEPATITIS

Bovine Type III Interferon Significantly Delays and Reduces the Severity of Foot-and-Mouth Disease in Cattle

(2012) Eva Perez-Martin et al.   JOURNAL OF VIROLOGY

IFN-λs

(2011) Sergei V Kotenko   CURRENT OPINION IN IMMUNOLOGY

Synergistic Inhibition of Enterovirus 71 Replication by Interferon and Rupintrivir

(2011) Hui-Chen Hung et al.   JOURNAL OF INFECTIOUS DISEASES

Antiviral activity of bovine type III interferon against foot-and-mouth disease virus

(2011) Fayna Díaz-San Segundo et al.   VIROLOGY

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

(2010) Andrew J. Muir et al.   HEPATOLOGY

Preclinical and Clinical Development of Pegylated Interferon-Lambda 1 in Chronic Hepatitis C

(2010) Eleanor L. Ramos   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Despite IFN-λ receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

(2009) K Witte et al.   GENES AND IMMUNITY

Interferon-λs: the modulators of antivirus, antitumor, and immune responses

(2009) Mingcai Li et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Enterovirus infections in neonates

(2009) Marc Tebruegge et al.   Seminars in Fetal & Neonatal Medicine